Intellectual property issues in a clinical trial: a corporate perspective.
Tanner Propp & Fersko, New York, New York 10016.
R S
RS
Fersko
M J
MJ
Connolly
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D003219:Confidentiality / Q000331:legislation & jurisprudence; D016265:Conflict of Interest / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000458:organization & administration*; D005380:Financing, Government / Q000331:legislation & jurisprudence; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D007373:Interinstitutional Relations; D009316:National Institutes of Health (U.S.) / Q000458:organization & administration*; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D012109:Research Support as Topic / Q000331:legislation & jurisprudence; D014481:United States